Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Obstet Gynecol ; 143(3): 435-439, 2024 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-38207328

RESUMO

Early pregnancy loss (EPL) is common, but patients face barriers to the most effective medication (mifepristone followed by misoprostol) and procedural (uterine aspiration) management options. This cross-sectional geospatial analysis evaluated access in New Mexico to mifepristone and misoprostol and uterine aspiration in emergency departments (comprehensive) and to uterine aspiration anywhere in a hospital (aspiration) for EPL. Access was defined as a 60-minute car commute. We collected data from hospital key informants and public databases and performed logistical regression to evaluate associations between access and rurality, area deprivation, race, and ethnicity. Thirty-five of 42 (83.3%) hospitals responded between October 2020 and August 2021. Two hospitals (5.7%) provided comprehensive management; 24 (68.6%) provided aspiration. Rural and higher deprivation areas had statistically significantly lower adjusted odds ratios for comprehensive management (0.03-0.07 and 0.3-0.4, respectively) and aspiration (0.03-0.06 and 0.1-0.3, respectively) access. Mifepristone and uterine aspiration implementation would address disparate access to EPL treatment.


Assuntos
Aborto Induzido , Aborto Espontâneo , Misoprostol , Gravidez , Feminino , Humanos , Mifepristona/uso terapêutico , Aborto Espontâneo/epidemiologia , Aborto Espontâneo/terapia , Misoprostol/uso terapêutico , Estudos Transversais , Aspiração Respiratória
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...